articleBloodJul 28, 2010BRONZE OA

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

MSMilena SantCAClaudia AllemaniCŢCarmen ŢereanuRDRoberta De AngelisRCRiccardo Capocaccia

Fondazione IRCCS Istituto Nazionale dei Tumori · Istituto Superiore di Sanità · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Changing definitions and classifications of hematologic malignancies (HMs) complicate incidence comparisons. HAEMACARE classified HMs into groupings consistent with the latest World Health Organization classification and useful for epidemiologic and public health purposes. We present crude, age-specific and age-standardized incidence rates for European HMs according to these groupings, estimated from 66,371 lymphoid malignancies (LMs) and 21,796 myeloid malignancies (MMs) registered in 2000-2002 by 44 European cancer registries, grouped into 5 regions. Age-standardized incidence rates were 24.5 (per 100,000) for LMs and 7.55 for MMs. The commonest LMs were plasma cell neoplasms (4.62), small B-cell lymphocytic…

Citation impact

956
total citations
FWCI
25.79
Percentile
100%
References
30
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Incidence (geometry)
  • Medicine
  • Lymphoma
  • Population
  • Myeloid
  • Myeloid leukemia
  • Chronic lymphocytic leukemia
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding